Plant-based diets and genetic risk for obesity

Four years ago, Paul Hud­son wel­comed in­vestors and an­a­lysts to Sanofi’s Cam­bridge, MA of­fice, in­tro­duc­ing his strat­e­gy for the French phar­ma gi­ant. Hud­son, who joined

The US Dis­trict Court for the South­ern Dis­trict of Cal­i­for­nia ruled last week in fa­vor of San Diego-based Shore­line Bio­sciences, re­ject­ing ar­gu­ments from Fate Ther­a­peu­tics